These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 37950156)

  • 21. Identification and validation of an immune prognostic signature in colorectal cancer.
    Li M; Wang H; Li W; Peng Y; Xu F; Shang J; Dong S; Bu L; Wang H; Wei W; Hu Q; Liu L; Zhao Q
    Int Immunopharmacol; 2020 Nov; 88():106868. PubMed ID: 32771948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of single-cell RNA sequencing and bulk RNA transcriptome sequencing reveals a heterogeneous immune landscape and pivotal cell subpopulations associated with colorectal cancer prognosis.
    Zhang Q; Liu Y; Wang X; Zhang C; Hou M; Liu Y
    Front Immunol; 2023; 14():1184167. PubMed ID: 37675100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma.
    Zhu J; Huang Q; Peng X; Luo C; Liu Z; Liu D; Yuan H; Yuan R; Cheng X
    Front Immunol; 2023; 14():1218661. PubMed ID: 37662906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constructing a Tregs-associated signature to predict the prognosis of colorectal cancer patients: A STROBE-compliant retrospective study.
    Ping G; Tian Y; Zhou Z
    Medicine (Baltimore); 2022 Nov; 101(47):e31382. PubMed ID: 36451426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma.
    Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y
    Front Oncol; 2021; 11():769727. PubMed ID: 34926275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
    Shen KY; Chen BY; Gao WC
    Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
    Zhang X; Shi X; Zhao H; Jia X; Yang Y
    Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of 14-gene signature prognostic model based on metastasis for colorectal cancer.
    Li T; Yu Q; Liu T; Yang W; Chen W; Jin A; Wang H; Ding L; Zhang C; Pan B; Wang B; Guo W
    J Clin Lab Anal; 2023 Jan; 37(1):e24800. PubMed ID: 36524971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and Validation of a Six Immune-Related Genes Signature for Predicting Prognosis in Patients With Stage II Colorectal Cancer.
    Li X; Xie M; Yin S; Xiong Z; Mao C; Zhang F; Chen H; Jin L; Lan P; Lian L
    Front Genet; 2021; 12():666003. PubMed ID: 34017356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in colorectal cancer.
    Zheng H; Liu H; Ge Y; Wang X
    Cancer Cell Int; 2021 Oct; 21(1):552. PubMed ID: 34670584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
    Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
    BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and validation of a novel senescence-related biomarker for thyroid cancer to predict the prognosis and immunotherapy.
    Hong K; Cen K; Chen Q; Dai Y; Mai Y; Guo Y
    Front Immunol; 2023; 14():1128390. PubMed ID: 36761753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer.
    Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X
    Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pyroptosis-related signature in colorectal cancer: exploring its prognostic value and immunological characteristics.
    Jiang P; Fan J; Huang S; Liu L; Bai M; Sun Q; Shen J; Zhang N; Liu D; Zhou N; Feng Y; Jiang J; Zhu J
    PeerJ; 2023; 11():e16631. PubMed ID: 38144182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma.
    Yang C; Huang S; Cao F; Zheng Y
    BMC Cancer; 2021 Nov; 21(1):1182. PubMed ID: 34740325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and Validation of a TNF Family-Based Signature for Predicting Prognosis, Tumor Immune Characteristics, and Immunotherapy Response in Colorectal Cancer Patients.
    Xiao Z; Nie K; Han T; Cheng L; Zhang Z; Peng W; Shi D
    J Immunol Res; 2021; 2021():6439975. PubMed ID: 34541005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A New Method for Constructing Macrophage-Associated Predictors of Treatment Efficacy Based on Single-Cell Sequencing Analysis.
    Lin J; Ran Y; Wu T; Wang Z; Zhao J; Tian Y
    J Immunother; 2024 Feb-Mar 01; 47(2):33-48. PubMed ID: 37982646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.